Basal STMN2 expression is characterized by natural heterogeneity, as suggested by the variability of STMN2 levels observed in sporadic ALS patients that did not correlate with the level of phosphorylated TDP-43 [8]. This evidence concerns the gene STMN2 and amyotrophic lateral sclerosis.